|
Oxidized Acetyl Dithranol
|
DB03037 |
|
|
Bb-3497
|
DB04368 |
|
|
GI-4000
|
DB05698 |
[A vaccine containing a heat-killed recombinant <em>Saccharomyces cerevisiae</em> yeast transfected with mutated forms of Ras, an oncogene frequently found in solid tumors, with potential immunostimulant and antitumor activity. [L112]] |
|
Arecoline
|
DB04365 |
[An alkaloid obtained from the betel nut (Areca catechu), fruit of a palm tree. It is an agonist at both muscarinic and nicotinic acetylcholine receptors. It is used in the form of various salts as a ganglionic stimulant, a parasympathomimetic, and a vermifuge, especially in veterinary practice. It has been used as a euphoriant in the Pacific Islands.] |
|
D-Levofloxacin
|
DB03034 |
[A synthetic fluoroquinolone (FLUOROQUINOLONES) antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.] |
|
1,8-Di-Hydroxy-4-Nitro-Anthraquinone
|
DB03035 |
|
|
3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate
|
DB04366 |
|
|
NP-50301
|
DB05662 |
[NP-50301 is an ophthalmic therapeutic eye drop treating post-menopausal Dry Eye Syndrome (DES). It is being developed by Nascent Pharmaceuticals. It is estimated that about 30% of postmenopausal women suffer symptoms of DES, which accounts for over 12 million women in the U.S. The majority of sufferers of DES are postmenopausal women; and clinical research around the world has suggested the benefits of both topical and systemic estrogen therapy in the treatment of DES in this population.] |
|
(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine
|
DB06993 |
|
|
Bilh 434
|
DB04330 |
|
|
S-9-(2-hydroxypropyl)adenine
|
DB03000 |
|
|
Monastrol
|
DB04331 |
|
|
(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone
|
DB06992 |
|
|
N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide
|
DB06991 |
|
|
D-JNKI-1
|
DB05660 |
[A synthetic, cell permeable peptide that blocks the MAPK-JNK signal pathway; has potential therapeutic value for long-term protection of both the morphological integrity and physiological function of the organ of Corti during times of oxidative stress.] |
|
4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID
|
DB06990 |
|
|
2-{[2-Oxo-2-(1-piperidinyl)ethyl]sulfanyl}-6-(trifluoromethyl)-4(1H)-pyrimidinone
|
DB03009 |
|
|
SB220025
|
DB04338 |
|
|
9r,13r-Opda
|
DB03007 |
|
|
5-fluoro-beta-L-gulosyl fluoride
|
DB03008 |
|
